Susceptibility of gram-negative anaerobic bacilli to gentamicin and other aminoglycosides.
D000693:Anaerobiosis; D001407:Bacillus / Q000187:drug effects*; D001439:Bacteroides / Q000187:drug effects; D004304:Dosage Forms; D005601:Framycetin / Q000494:pharmacology; D005673:Fusobacterium / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology*; D007201:Indicator Dilution Techniques; D007612:Kanamycin / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D010303:Paromomycin / Q000494:pharmacology
D004304:Dosage Forms; D005839:Gentamicins; D005601:Framycetin; D007612:Kanamycin; D010303:Paromomycin; D009355:Neomycin; D010100:Oxygen